In spite of shorter disease-free survival of invasive ductal breast carcinoma patients with MDM2-expressing tumors, these tumors were significantly smaller and fewer patients with the MDM2-expressing tumors presented with LN metastases [21]. This evidence concerns the gene MDM2 and invasive ductal breast carcinoma.